由肺纤维细胞衍生的细胞外囊泡和可溶性因子减轻了弹性酶诱导的肺损伤
Luke van der Koog1, Myrthe J Boerrigter1, Iris C Gorter2
1Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands; GRIAC, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, the Netherlands.
European journal of pharmacology
|April 27, 2024
概括
肺纤维细胞细胞外囊泡 (EVs) 和可溶性因子 (SFs) 显示为治疗肺气有前途. 这些成分改善了慢性阻塞性肺病 (COPD) 模型中的肺组织修复和功能.
科学领域:
- 再生医学是一种再生医学.
- 肺部研究 肺部研究
- 细胞生物学 细胞生物学
背景情况:
- 慢性阻塞性肺病 (COPD) 的特征是肺气,这是由于再生能力受损而导致的肺功能丧失.
- 包括细胞外囊泡 (EVs) 在内的介质干细胞秘密体正在研究肺部修复.
- 纤维细胞分泌体中可溶性因子 (SF) 在COPD肺部再生中的作用在很大程度上尚未被探索.
研究的目的:
- 研究来自肺纤维细胞的细胞外囊泡 (EVs) 和可溶性因子 (SFs) 的治疗潜力,用于治疗肺气.
- 为了评估EV和SF丰富分量的效应,以弹性酶诱导的肺损伤在体外和体内.
主要方法:
- 从培养的MRC-5肺纤维细胞中净化和表征EV和SF.
- 精密切割肺切片 (PCLS) 用EV和SF丰富的分量进行处理,以评估对弹性酶诱导的肺气的影响.
- 肺纤维细胞衍生的EV和SF度的体内评价在弹性酶诱导肺的小鼠模型中.
主要成果:
- 富含EV和SF的部分可以预防和改善PCLS的肺气,减少肺损伤和升调膜上皮细胞标记物.
- 在体内治疗减弱了肺组织的破坏,改善了肺功能,并增强了膜上皮细胞标记物基因表达.
- 无论是EV还是SF,都显示出促进对酶体再生和恢复肺机械的潜力.
结论:
- 肺纤维细胞衍生的EV和SF在治疗肺损伤和肺气方面具有治疗潜力.
- 在COPD模型中,这些成分可以促进气泡膜修复和改善肺功能.
- 对EV和SF度的进一步研究可能会导致对肺气的新治疗方法.
相关概念视频
Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.


